Expected earnings - BridgeBio Oncology Therapeutics Inc.
Source: US Earnings Reports
BridgeBio Oncology Therapeutics Inc. (BBOT) is expected to report $-0.61 for Q4 2025
BridgeBio Oncology Therapeutics Inc Com
NASDAQ: BBOT
BBOT Trading
-2.9% G/L:
$9.72 Last:
6,785 Volume:
$9.96 Open:
